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Abstract
Background: MiRNAs play important roles in cellular control and in various disease states such
as cancers, where they may serve as markers or possibly even therapeutics. Identifying the whole
repertoire of miRNAs and understanding their expression patterns is therefore an important goal.
Methods: Here we describe the analysis of 454 pyrosequencing of small RNA from four different
tissues: Breast cancer, normal adjacent breast, and two teratoma cell lines. We developed a
pipeline for identifying new miRNAs, emphasizing extracting and retaining as much data as possible
from even noisy sequencing data. We investigated differential expression of miRNAs in the breast
cancer and normal adjacent breast samples, and systematically examined the mature sequence end
variability of miRNA compared to non-miRNA loci.
Results: We identified five novel miRNAs, as well as two putative alternative precursors for
known miRNAs. Several miRNAs were differentially expressed between the breast cancer and
normal breast samples. The end variability was shown to be significantly different between miRNA
and non-miRNA loci.
Conclusion: Pyrosequencing of small RNAs, together with a computational pipeline, can be used
to identify miRNAs in tumor and other tissues. Measures of miRNA end variability may in the future
be incorporated into the discovery pipeline as a discriminatory feature. Breast cancer samples show
a distinct miRNA expression profile compared to normal adjacent breast.
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Background
MicroRNAs (miRNAs) have rapidly emerged as an impor-
tant class of short endogenous RNAs that act as post-tran-
scriptional regulators of gene expression by base-pairing
with their target mRNAs. The approximately 22 nucle-
otides (nt) long mature miRNAs are processed sequen-
tially from longer hairpin transcripts by the RNAse III
ribonucleases Drosha [1] and Dicer [2,3]. To date more
than 9539 miRNAs have been annotated in vertebrates,
invertebrates and plants of which 706 are human accord-
ing to the miRBase database release 13.0 in March 2009
[4,5], and recent bioinformatic predictions combined
with array analyses, small RNA cloning and Northern blot
validation indicate that the total number of miRNAs in
vertebrate genomes is significantly higher than previously
estimated and may be thousands [6-8].
Several papers have already described the usefulness of
miRNAs as diagnostic molecules in e.g. cancer [9,10] and
their potential as therapeutics is being explored [11]. One
of the obvious and important goals for understanding
more precisely the role and importance of miRNAs in dif-
ferent cellular contexts is to identify all_miRNA species of
a given organism and their expression profiles. The dimin-
ishing costs of High-Throughput (HT) sequencing tech-
niques are making these increasingly more popular for
such discovery and profiling efforts [12,13]. In conse-
quence, large amounts of data will be generated, and
appropriate bioinformatics methods are needed to deal
with the data.
We developed a pipeline combining exact and probabilis-
tic methods to analyse 454 small RNA data for the pur-
pose of identifying putative new miRNAs. This task can be
divided into two objectives: finding and quantifying
expressed genomic regions giving rise to small RNA reads,
and scoring these regions as potential new miRNAs. Our
approach to the first part of this problem was to retain as
much sequence information as possible, despite possible
sequencing errors and redundant mapping, thus increas-
ing the amount of available data. For the second objective,
we trained a Support Vector Machine (SVM) for reliable
classification of potential miRNAs.
The pipeline was used to analyze deep sequencing data
generated from four different human tissue samples:
Breast cancer, normal adjacent breast, and two teratoma
cell lines. We chose to analyze breast cancer associated
miRNAs, as these represent an important case for finding
miRNA based biomarkers for cancer diagnosis. The dis-
covery of novel miRNAs, as well as understanding the
expression of already known miRNAs in these tissues, is
therefore of medical interest. The two teratoma cell lines
were included in the analysis with the aim of identifying
novel miRNAs. Given that teratoma can develop into
many different tissue types, we hypothesized that these
samples could potentially express different miRNAs than
normal samples and thus be a good source of new miR-
NAs.
In several papers it has been observed that the 5' end of
metazoan mature miRNAs is more precisely defined than
the 3' end [14-17]. Recently Seitz et al. reported the first
systematic analysis of this phenomenon in flies, showing
that the population of sequences derived from known
miRNAs varies significantly less in the 5' ends compared
to the 3' ends [18]. Furthermore, they showed that the
observed 5' precision is not caused by imprecise process-
ing by the two endonucleases Drosha and Dicer, but by an
event selecting precise 5' ends at or after the 2'-O-methyl-
ation of the 3' end and Argonaute2 loading of the miRNA
guide strand. These results have yet to be confirmed in a
systematic way in organisms other than flies, so we inves-
tigated whether the results could be confirmed by our
data.
Results and discussion
Data
Small RNA fractions were obtained from tissue samples of
breast cancer (BC), normal adjacent breast tissue (BN),
and two teratomas (CRL-7826 and CRL-7732), see Meth-
ods for details. Using 454 pyrosequencing [19] we
obtained between 64894 and 302556 sequence reads
from each sample. For BC, RNA up to a length of 100 nt.
was extracted with the aim of identifying miRNA precur-
sors as well as the mature product. No such precursors
were found (data not shown), so for the remaining sam-
ples an upper size limit of 40 nt was used. All analyses of
known miRNAs were performed with reference to miR-
Base 10.1 [4,5] unless otherwise stated.
Sequence processing
Using a hidden Markov model for cDNA-insert recognition
A common step in many sequencing approaches is the
ligation of short flanks of known sequence to the ends of
the cDNA. These flanks must subsequently be identified
and removed from the final sequence reads before analy-
sis. Due to errors in both the production/ligation of these
flanking sequences and in the sequencing reaction itself,
these flanks may not always appear perfect in the final
reads. The simplest approach for identifying the flanks is
to only accept sequences that match perfectly to the
expected flanking sequences, but this may potentially lead
to a large loss in the amount of data available for further
analysis. In our case, the flank regions were often impre-
cise, and only up to 24% of the reads would pass such per-
fect matching criteria in the different samples (see Figure
1). Therefore we clearly needed a way to identify the
flanks correctly despite some irregularities in the
sequences. Simple regular expressions or rule-based meth-BMC Medical Genomics 2009, 2:35 http://www.biomedcentral.com/1755-8794/2/35
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ods can be used but depend on the incorporation of prior
expectations into the procedure, e.g. the position or
number of expected errors. We found that even allowing
two errors in a flank sequence of length 24 did not allow
for robust recognition, and allowing higher error rates
made the flank recognition too degenerate to be reliable.
To circumvent these problems, we instead applied a prob-
abilistic approach, by training a hidden Markov model
(HMM) [20] to recognize the flanking sequences. The
HMM was based on an initial model corresponding to the
expected flanking sequences, with low probabilities for
errors. A random subset of the data was used to train this
model (unsupervised learning), letting the model auto-
matically adjust to common variations in the flanks, so
that the final model reflects the actual, observed data. By
using the trained model and a suitable score cutoff we
could reliably recognize the flanks for at least 63% of all
sequences in each sample, see Figure 1. This approach
increased the amount of usable reads by between a factor
of three and 26 in the different samples. Thus an HMM
offers a simple approach to drastically increase the
amount of recognizable sequence inserts in the light of
noise from flank ligation and sequencing.
Mapping the reads
The process of mapping the reads back to the genome is
challenged both by reads mapping to multiple places in
the genome, and by differences between read and the
genome sequence. Such differences may occur both due to
natural variation such as RNA-editing and SNPs, or more
commonly errors in the sequencing process. To consider
only perfect matches can therefore lead to an unaccepta-
ble loss of data. Based on these considerations, and the
observed error rate in the flanks, we chose to record
matches with sequence identity (mismatches and indels)
as low as 90% between the read and the genomic
sequence. For each read, we kept only the best match(es),
i.e. those matches with the minimal number of mis-
matches and/or indels. To avoid any ambiguities in the
mapping that heuristic algorithms such as BLAST [21]
might introduce, we used the non-heuristic suffix-array
based program Vmatch [22]. When using a low sequence
identity cut-off, one might expect a high number of reads
mapping randomly to multiple places in the genome,
adding more noise than information to the data. But as
can be seen in Figure 2, the majority of both perfect and
imperfect matches mapped to unique places in the
genome.
Given the short length and functional redundancy of miR-
NAs, it is not surprising that many known mature miRNA
sequences map to more than one place in the genome. Of
the 564 human mature miRNA sequences in miRBase
10.1, we found that 462 (82%) mapped uniquely to one
place in the genome (data not shown). As a compromise
between the conflicting interests of accuracy of mapping
and retaining information, we chose to keep reads with up
to five equally good matches. This retained 98% of the
known miRNAs, and 89% of all the mapped sequence
reads.
To determine the origin of the mapped reads, we checked
their overlap with genomic annotations, as detailed in the
methods section. As expected miRNAs constituted the
largest fraction of reads (Figure 3), with other ncRNAs
being the second largest category. A fraction of reads not
overlapping any of the known annotations was also
observed. Similar to what has been reported elsewhere
[12], we also observed a small number of perfect hits to
piRNA sequences in all samples (data not shown).
Differential expression in BC and BN samples
Cloning frequencies from short read libraries can be used
to analyse relative expression changes between samples
[17,23]. To identify differentially expressed miRNAs in
the breast cancer and normal breast libraries, we used the
Sequence recovery Figure 1
Sequence recovery. Extracting the actual cDNA insert 
from a sequencing construct. The dark grey bars show the 
total number of reads in each of the four samples. Medium 
grey bars show the number of reads where the insert could 
be reliably recognized using an HMM, light grey bars show 
the number of inserts recognized by perfect string matching 
to the expected flanking region. Though a sizable fraction of 
the raw data is lost due to errors in flanks in all cases, the 
HMM approach recovers a much larger part of the data.
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method described by Kal et al. [24] with a False Discovery
Rate of 0.05 [25]. This approach identified eight differen-
tially expressed miRNAs, see Table 1. Five of these were
overexpressed in breast cancer compared to normal breast
tissue, including the well-known breast cancer associated
miR-21 [26-29]. MiR-200b, miR-200c and miR-23a have
similarly been reported to be overexpressed in cancer cells
[28,30,31], consistent with our findings. Let-7a, which we
found to be highly overexpressed in breast cancer, have in
other studies been reported to have low expression in can-
cer cells [26,27,29], though the expression level has also
been shown to vary between specific tumor subtypes [32],
underscoring the complexity of miRNA regulation in can-
cer biology.
Among the miRNAs overexpressed in the normal breast
compared to breast cancer samples, miR-22 has previ-
ously been reported as highly expressed in mammary pro-
genitor cells [33]. Our findings are therefore consistent
with previous reports, as well as adding new miRNAs to
Mapping precision Figure 2
Mapping precision. The effect of allowing imperfect and/or 
multiple mappings of sequence reads. The pie chart shows 
the fraction of reads that map perfectly to only one unique 
place in the genome (PU), map imperfectly, but still to one 
unique place in the genome (IU), map perfectly but redun-
dantly two to five places in the genome (PR), map imperfectly 
and redundantly (IR), or map repetitively, more than five 
places, either perfectly (repP) or imperfectly (repI). The 
majority of reads map uniquely to one place in the genome, 
both for perfect and imperfect matches.
PU
IU
PR IR
repI
repP
Origin of reads Figure 3
Origin of reads. The origin of reads after mapping to the 
genome, as determined by overlap with genomic annotation. 
As expected miRNA derived reads constituted the largest 
category, while (~6%) of reads were of unknown origin (no 
annotation on the coordinates and strand corresponding to 
the read). Not shown in the figure is a small number of 
matches to piRNAs.
miRNA
Other ncRNA
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Table 1: Differentially expressed miRNAs in BN and BC.
miRNA BN BC Fold change
mir-200b 22.8 (1) 27122.2 (2325) 1189.6
mir-200c 45.5 (2) 44072.2 (3778) 968.6
mir-21 22.8 (1) 15363.4 (1317) 673.8
mir-378 68944.3 (3027) 466.6 (40) -147.8
let-7a 2186.5 (96) 50313.2 (4313) 23.0
mir-320 136180.4 (5979) 19376.4 (1661) -7.0
mir-23a 11319.9 (497) 44748.8 (3836) 4.0
mir-22 25646.3 (1126) 7150.9 (613) -3.6
MiRNAs significantly differentially expressed in normal breast (BN) 
and breast cancer (BC) samples, with False Discovery Rate of 0.05. 
Columns show the miRNA id, the observed expression in BN and BC 
as parts-per-million (ppm) and raw read counts in parentheses, and 
the relative fold change. The ppm values were based on the total 
number of 19 – 24 nt long reads in each library. Five miRNAs were 
found to be overexpressed in BC compared to BN (positive fold 
change), while three were underexpressed (negative fold change).BMC Medical Genomics 2009, 2:35 http://www.biomedcentral.com/1755-8794/2/35
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the repertoire of miRNAs showing different expression
profiles for breast cancer versus normal breast samples.
Identifying new miRNAs
Using an SVM for miRNA recognition
To identify new miRNAs in the data, we first predicted the
secondary structure around a genomic match using RNA-
fold [34-36]. The structure prediction was done in asym-
metrical windows of 15 bases to one side of the match and
60 to the other. These window lengths were chosen as the
combination that generated hairpin structures for most of
the known miRNAs (data not shown).
The predicted structures were then scored using an SVM
trained to recognise miRNA precursor hairpins, an
approach that has previously been used successfully for
miRNA discovery [37-41]. Our SVM was trained on 15 dif-
ferent sequence and structure features, describing both the
mature miRNA and its precursor (see Lindow et al., 2007
[42] and Methods for details). The SVM was trained using
known miRNAs from miRBase [4,5] as positive examples,
ensuring that miRNA-family members were kept together
to avoid overfitting. In generating the negative training
set, we wanted to mimic the actual task that the final SVM
would be presented with: Separating true miRNAs from
(fragments of) various other transcripts present in the
sequencing data. We therefore sampled the negative set
from a combination of sources: mRNA, non-miRNA
ncRNA, and random genomic locations. To make the SVM
more specific for distinguishing between genuine miRNA
hairpin structures and miRNA-like structures we con-
strained the sampled structures by requiring that their
sequence/structure features be within specific quantiles of
the distributions observed for known miRNAs (detailed in
Methods).
By training on these sets, we obtained a sensitivity of 80%
and a specificity of 98% on an independent test set. Meas-
ures of sensitivity and, in particular, specificity, are of
course completely dependent on the test data used. Given
the diffculty of our training and test sets, we expect the
specificity on the actual data to be higher. A high specifi-
city is particularly important in a HT analysis setting,
where even a seemingly good specificity may generate
many false positives.
Determining expression requirements
The use of imperfect and non-unique matches increases
the number of mappings to the genome, and therefore
also the risk of generating false predictions. To take this
into account, we examined how to incorporate the differ-
ent types of matches into an expression requirement for
novel miRNA loci. There is some variation in the exact
mature miRNA excised from a particular miRNA precursor
[12] (discussed below), so to evaluate expression we gen-
erated overall loci of the genomic matches, merging over-
lapping sequence matches into the same potential new
miRNA. To avoid 'locus-walking', i.e. sequentially over-
lapping matches expanding a locus beyond what is rea-
sonable for a mature miRNA, we restricted these loci to
two-base overhangs compared to the match representing
the most abundant read (see Methods for details).
Figure 4a shows which fraction of the total possible
observed miRNAs (the 267 known miRNA for which
there is evidence in any of the samples) were observed at
different expression levels, and using different matching
and mapping criteria. As expected, most miRNAs were
recovered by allowing all criteria and having low expres-
sion requirements. The redundant mappings were more
important for miRNA recovery than imperfect matches,
suggesting that most miRNAs were represented by at least
one perfectly matching read.
Since the aim was to identify new miRNAs, we explored
the ratio between recovered known miRNAs and the total
number recovered loci at different expression thresholds
(Figure 4b). The greatest increase in this ratio was
observed when going from a threshold of two to three
reads for a locus, with perfectly matching reads generally
having higher ratios.
To balance high recovery of miRNAs with the greater
miRNA/total loci ratio obtained by requiring perfect
matching, we chose to require at least one perfectly
matching read for a candidate miRNA locus, and a mini-
mum total expression (perfect or imperfect matches) of
three reads. The reads could be mapped either uniquely or
redundantly. This gave only a 2% loss in recovered known
miRNAs compared to not requiring any perfect matches,
but a three-fold increase in the miRNA/total loci ratio. All
loci that passed these criteria were considered likely
miRNA candidates, but for a locus to be considered a reli-
able de facto miRNA we additionally required that perfect
matching reads were observed in at least two tissues.
Pipeline results
Combining the SVM scoring and the expression criteria
described above, yielded 20 candidate miRNA loci, with
expression ranging from the minimum requirement of
three up to more than 1400 reads (see Tables 2 and 3).
Two of these loci represented potential new precursors for
already known miRNAs. Eleven of the loci were repre-
sented by perfect mapping reads in at least two tissues,
and were thus considered real miRNAs. While writing this
paper a new version of miRBase was released, now includ-
ing six of these miRNAs (mir-1180, mir-1271, mir-1287,
mir-1296, mir-1301, and mir-1908). The remaining new
miRNAs and the additional candidate loci (Additional file
1) are described below.BMC Medical Genomics 2009, 2:35 http://www.biomedcentral.com/1755-8794/2/35
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Recovery of known miRNA, and fraction of known miRNA in the data Figure 4
Recovery of known miRNA, and fraction of known miRNA in the data. (a): Recovery of known miRNAs with differ-
ent matching criteria and abundance requirements. MiRNA fractions are given with respect to the total number of miRNA loci 
observed in the data. Abundance levels are minimum expression threshold for a locus. (b): Fraction of known miRNA to total 
number of loci in the data, at different match criteria and (minimum) abundance levels. Perfect, unique: Allow only reads that 
match the genome perfectly, and in one place only. Imperfect: Also allow reads that match imperfectly (down to 90% identity), 
but still in only one position. Multiple mapping: Allow only reads that match perfectly, but up to five places in the genome. All: 
Allow both perfect and imperfect matching, and mapping up to five places.
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Table 2: Novel miRNAs and miRNA candidates. 
Locus ID Coordinates Sequence Status
12783 chr13:23634608–23634629(+) TCTGCAAGTGTCAGAGGCGAGG miRNA
19011 chr16:3870478–3870503(-) GGCGGCGGCGGCGGCGGAACGG miRNA
41039 chr5:92982172–92982192(-) TGACAGCGCCCTGCCTGGCTC miRNA
49828 chr9:96612080–96612101(+) GAGAGCAGTGTGTGTTGCCTGG miRNA
53356 chrX:151975564–151975586(-) CGGCGGCGGCGGCGGCGGACGGG miRNA
52195 chrX:49662029–49662050(+) TAATCCTTGCTACCTGGGTGAG alt
37600 chr4:17057782–17057802(-) TCGAGGAGCTCACAGTCTAGT alt
6219 chr10:97814116–97814137(-) TTCAGCCAGGCTAGTGCAGTCT cand
19702 chr17:59060613–59060634(+) ACTGGCTTGTGGCAGCCAAGTG cand
21361 chr17:15095708–15095729(-) TGCTGGGGGCCACATGAGTGTG cand
23602 chr19:764627–764645(+) TTGGCCATGGGGCTGCGCG cand
25697 chr2:11825070–11825091(+) TAATGGCCAAAACTGCAGTTAT cand
32226 chr22:49459945–49459967(+) CCCGGGGCCAGCGCCGTGGTCGT cand
52275 chrX:128945787–128945807(+) CGGCGGGCGGCGGGGCGGGGC cand
Columns show the locus ID, genome coordinates, sequence, and miRNA status: miRNA (submitted to miRBase), alt (candidate alternative 
precursor for known miRNA), or cand (candidate miRNA). The most highly expressed read for a locus is shown. Only loci that have not been 
included in miRBase yet are shown.BMC Medical Genomics 2009, 2:35 http://www.biomedcentral.com/1755-8794/2/35
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Novel miRNAs
None of the five remaining novel miRNAs were found to
be part of a cluster (no other miRNAs within 10 Kb up-
and downstream). Expression and conservation for these
loci was generally low, probably reflecting that most
highly expressed or conserved miRNAs have been identi-
fied by now. Three loci were intronic (12783, 49828,
53356), one of these (53356) overlapping repeat annota-
tion as well. In addition to being intronic to one gene,
locus 53356 was found to also overlap the 5' UTR of an
antisense gene (PNMA3, [Genbank: NM_013364]), sug-
gesting that antisense transcription might play a part in
regulation of these overlapping genes.
One locus, 19011, only overlapped repeat annotation, but
was part of a ~600 base pair highly conserved block,
which might be transcribed as part of the 5' UTR for the
nearby gene CREBBP  [Genbank: NM_004380]. Two
mRNA ([Genbank: U47741], [Genbank: U85962])
encompassing the region seem to confirm this. The repet-
itive CGG unit of the mature sequence was also found in
the sequence of locus 53356 and candidate locus 52275.
The fifth new miRNA, locus 41039, overlapped coding
exon annotation. Approximately 75 bases downstream of
this locus an evolutionarily conserved secondary structure
is predicted by EvoFold [43], indicative of other ncRNA or
structure based regulation in the area.
Additional candidate miRNA loci
The remaining seven candidate loci were all represented
by at least three reads, but did not fulfill our expression
requirements (expression in at elast two tissues) for a reli-
able new miRNA. Additional data will be required to con-
firm these as true miRNAs. Five of the candidate loci were
intronic (6219, 21361, 25697, 19702, 52275), with three
of them overlapping repeat annotation as well (25697,
19702, 52275). The last two candidates (32226,23602)
overlapped exons, though in the case of locus 23602 in
the antisense direction. Conservation of the non-exonic
candidate loci was low, with the exception of locus 52275.
Alternative precursors for known miRNAs
A mature miRNA sequence may be encoded by more than
one hairpin precursor locus, eg. the mature miR-124 is
encoded by three distinct loci. Our data suggested that
two known single-locus miRNAs, miR-151 and miR-500,
may be encoded by more than one locus in the genome:
Reads corresponding to these miRNAs could be mapped
both to their official, miRBase annotated precursor, and to
alternative predicted hairpin structures elsewhere in the
genome. In such cases short-read data alone cannot iden-
tify the true precursor with certainty, but the following
features should be noted:
In contrast to the official mir-151 locus, the predicted
alternative precursor showed only little conservation. Fur-
Table 3: Annotation of the miRNA candidates. 
Locus ID Annotation Gene RefSeq Expression Phastcons Status
21019 Intron - AC124066.2 1,12,2,1 0.57 miR-1180
38843 Intron ARL10 - 0,0,3,2 0.99 miR-1271
6150 Intron C10orf33 - 4,0,1,4 1 miR-1287
6746 Intron JMJD1C - 1,4,2,1 1 miR-1296
27738 Intron DNMT3A - 3,12,7,4 0.99 miR-1301
8884 intron FADS1 NM_013402 2,0,9,2 0.34 miR-1908
37600 repeat - - 136,933,146,220 0.03 alt.miR-151
52195 intron CLCN5 NM_000084 0,4,0,0 1.00 alt.miR-500
12783 intron PATA13 NM_153023 1,1,3,0 0.01 miRNA
19011 repeat - - 8,2,0,0 0.98 miRNA
41039 exon C5orf21 NM_032042 0,2,1,0 0.46 miRNA
49828 intron ONPEP NM_032823 2,1,4,1 0.00 miRNA
53356 intron PNMA5 NM_052926 7,3,0,0 0.03 miRNA
6219 intron AK091396 AK091396 0,3,0,0 0.08 Cand
19702 intron MAP3K3 NM_203351 84,0,1,9 0.08 Cand
21361 intron PMP22 NM_000304 3,0,1,0 0.06 Cand
23602 exon* PRG2 NM_002728 0,0,3,0 0.60 Cand
25697 intron LPIN1 NM_145693 0,3,0,0 0.02 Cand
32226 exon SHANK3 NM_001080420 3,0,0,0 0.99 Cand
52275 intron BCORL1 NM_021946 3,0,0,0 0.99 Cand
Columns show locus ID for the putative miRNAs, annotation, gene name and RefSeq accession (where applicable), expression (read counts), and 
conservation. For locus 6219, where no proper gene name or RefSeq is available, GenBank accession is given instead. 'Expression' shows the raw 
read count for BN, BC, CRL-7826, CRL-7732, and is summed for all reads in the locus. 'Phastcons' is the average Phastcons score [52-54]. 'Status' 
shows if a locus is a miRNA or a candidate locus. The names of miRNAs that have already been included in miRBase are shown, with 'alt.miR-NNN' 
designating a predicted alternative precursor for miR-NN. *Anti-sense.BMC Medical Genomics 2009, 2:35 http://www.biomedcentral.com/1755-8794/2/35
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thermore, while most reads map equally well both places,
there were 166 reads that mapped only to the official pre-
cursor, and only three that mapped exclusively to the
alternative precursor. The data therefore lends more sup-
port to the official precursor, though miRNAs derived
from the alternative precursor cannot be ruled out.
The official mir-500 precursor is located within a 12 kb
intronic cluster of seven annotated, conserved miRNA
precursors. Our predicted alternative precursor is also
located within this cluster, and similarly coincides with a
peak of high conservation (see Figure 5). We therefore
consider this a likely bona fide miR-500 precursor.
Mature miRNA end precision
The mature miRNA 5' end is less variable than the 3' end
To investigate the end variability of miRNAs we analyzed
the 219 miRBase miRNAs for which we observed three or
more reads in our data. Figure 6a shows how the miRNA
precursor is processed by two different endonucleases to
produce a mature miRNA product from either side of the
hairpin. The first cut by Drosha is distal to the loop of the
precursor hairpin, the second cut by Dicer is proximal to
the loop. Comparing our reads to the annotated end posi-
tions, we calculated the absolute average deviation for 5'
and 3' ends, and for loop distal and loop proximal ends
compared to the miRNA precursor (Figure 6b). The 5'
ends can be seen to be much less variable than the 3' ends,
a difference that is highly significant (p < 10-15, Wilcoxon
rank-sum). The differences between the loop proximal
and loop distal ends are much less pronounced, so the
observed 5' and 3' variation is not an effect of position
within the hairpin.
Furthermore, the high 3' variability could not be immedi-
ately explained by 3'→5' degradation events as we found
the variation to be broadly distributed on both sides of
the most frequent 3' end (see Additional file 2).
Figure 6c shows the 5' versus 3' variability for individual
miRNAs. Of the 219 miRNAs examined, only 7 (3%)
showed most variability in the 5' end.
miRNA* 5' ends are also less variable than their 3' ends
When processing the miRNA precursor, Drosha and Dicer
produce a miRNA:miRNA* duplex with a fixed 2 nucle-
otide 3' overhang. If we assume that the population of
miRNA and miRNA* sequences derived from Drosha and
Dicer processing in large remains unaltered, we would
expect the 5'/3' cleavage end pairs of the miRNA:miRNA*
duplexes to be equally precisely defined. By analyzing
reads from 79 miRNAs where the miRNA* was also
expressed, we found the opposite to be true (Figure 7): the
5' end in a cleavage end pair was significantly less variable
than the 3' end and this was true for both miRNA (p = 1.2E
- 11, Wilcoxon rank-sum) and miRNA* 5' (p = 5.9E - 13)
ends.
In summary our results on human miRNAs were consist-
ent with those obtained for flies by Seitz et al. [18], and
support their notion that the precise 5' ends of both
miRNA and miRNA* sequences are due to a narrowing
selection on a more variable sequence population pro-
duced by Drosha and Dicer.
miRNA loci have less variable 5' ends than non-miRNA loci
To see whether the precisely defined 5' end is a special sig-
nature of mature miRNA sequences compared to other
MiRNAs and conservation near the alternative mir-500 locus Figure 5
MiRNAs and conservation near the alternative mir-500 locus. Location and conservation of the proposed alternative 
mir-500 compared to the known mir-500 and nearby miRNA genes. Shown in black is the mature miR-500 sequence within the 
alternative precursor. The red blocks show currently known miRNA precursors, and the blue peaks show Phastcons conserva-
tion [52-54]. The mature miR-500 sequence is highly conserved in the alternative precursor. Figure generated via the UCSC 
genome browser [47].BMC Medical Genomics 2009, 2:35 http://www.biomedcentral.com/1755-8794/2/35
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small RNAs in our data, we analyzed all our genomic loci
with at least 10 mapped reads. The variability (average
deviation from the most abundant read) was calculated as
described in Methods. The distributions of 5' end variabil-
ity (Figure 8), were significantly different for the two
classes (Wilcoxon test, P < 2.2E - 16). The distributions of
3' end variability were similarly found to be significantly
different (Wilcoxon test, P < 0.0033), though the distribu-
tions overlap far more (Figure 8) thus being less informa-
tive.
Together these results suggest that even though the distri-
butions overlap, the end variation measures for a given
candidate locus has some discriminatory power, and
could be incorporated into a probabilistic miRNA discov-
ery pipeline, provided there are enough reads from a given
locus. Five of our putative novel miRNA loci had ten or
more reads, and for these we compared the end variation
to the miRNA and non-miRNA distributions. Only the
locus 53356 (10 observed reads), had a 5' end deviation
above what we observed for the known miRNAs. This sug-
5' and 3' miRNA end variation Figure 6
5' and 3' miRNA end variation. a) The figure conceptually shows how the tiling of reads in a miRNA precursor produces 
variation in the 5'/3' ends and loop proximal/distal ends of observed miRNA (blue reads) and miRNA* (orange reads) 
sequences. Expression counts are shown next to each read. In the figure miR-22 reads from the BN sample is used as example. 
b+c) The 219 known mature miRNAs expressed with a minimum total count of 3 in our samples. b) The cumulative distribu-
tion of mean absolute deviations from the annotated mature miRNA end. c) The mean absolute deviation of the 5' end versus 
the 3' end for each of the 219 expressed mature miRNAs.BMC Medical Genomics 2009, 2:35 http://www.biomedcentral.com/1755-8794/2/35
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gests that it may not be such a reliable candidate, though
having more reads available for the end deviation calcula-
tions would be preferable.
ncRNA with miRNA-like sequence features
Kawaji et al. recently described a number of specific small
RNA species derived from longer ncRNAs [44], in particu-
lar tRNAs, which seem to be processed in a tissue specific
manner. It is interesting in this connection that when
inspecting the 32 non-miRNA loci with 5' end variability
less than 0.1 in our data, almost half (15) were annotated
as tRNA derived, supporting the notion that these are
non-random subspecies of longer tRNA transcripts. While
none of these had SVM-scores indicative of a miRNA-like
precursor (unsurprising given their tRNA origin), we
observed that a number of high scoring hairpins were pre-
dicted in other ncRNAs, with read patterns sometimes
consistent with that observed for miRNAs. For example
the chromosome 17 cluster of five repetitive C/D box
snoRNA U3 genes was strongly represented by a read of
approximate length 22, derived from the 3' portion of the
snoRNA gene (Additional file 3). Highly expressed reads
from predicted hairpins were also observed in pseudo-
genes for rRNAs: though a diffuse pattern of reads was
observed, there were some dominant species of reads
(Additional file 3). It would be interesting in future stud-
ies to see if hairpin structures inside other ncRNA genes
are targeted capriciously by the miRNA processing
machinery. Such ncRNA genes or pseudo genes could
then easily be recruited as new miRNAs during evolution.
Conclusion
We have analyzed small RNA sequencing data from
human breast cancer tumor samples, normal adjacent
breast, and two teratoma cell lines, with the aims of eval-
uating differential miRNA expression between breast can-
cer and normal adjacent breast, and to identify novel
miRNAs. Several differentially expressed miRNAs were
identified, adding to the growing evidence for miRNA
involvement in cancer.
To identify novel miRNAs we developed a pipeline which
incorporates a hidden Markov model to extract the actual
cDNA from the sequencing construct, non-heuristic map-
ping of the reads to the genome allowing both sequence
variation and mapping to several places in the genome,
and a support vector machine to score predicted hairpins.
Using this pipeline we identified two putative alternative
loci for known miRNAs, and 11 new miRNAs. Six of these
End variation of miRNA and miRNA* pairs Figure 7
End variation of miRNA and miRNA* pairs. End variation of 79 precursors having both the mature miRNA and miRNA* 
region expressed. A) The cumulative distribution of mean absolute deviations from the annotated mature miRNA and miRNA* 
ends. B) Plotting the 5' versus 3' mean absolute deviations for all 5'/3' cleavage end pairs of the miRNA:miRNA* duplexes.BMC Medical Genomics 2009, 2:35 http://www.biomedcentral.com/1755-8794/2/35
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have in the meantime been independently identified by
others and included in miRBase.
Inspecting the read sequences derived from mature
miRNA and miRNA* pairs, we found that the 5' ends were
significantly less variable than the 3' ends. Our observa-
tions support previous results in flies [18] suggesting that
the low 5' variability is due to a selection on the 5' end
sequences after Drosha and Dicer processing of the pre-
cursor miRNA. Furthermore, when inspecting reasonably
expressed miRNA loci vs. non-miRNA loci, we found that
the 5' end variability had some discriminatory power. As
the depth of sequencing improves with the advent of still
more powerful HT sequencing technologies, we envision
that this feature might be integrated in future miRNA dis-
covery pipelines.
Methods
Samples
Tissue
Five different human breast cancer (BC) tissue samples
(about 200 mg in total) and their corresponding normal
adjacent tissues (BN) were obtained from the MAMBIO
repository at Herlev University Hospital, and stored at -
80°C until RNA purification and fractionation. The col-
lection of patient samples for the MAMBIO-repository
was approved by the Science Ethics Committee for the
former Københavs Amt and by the Danish Data Protec-
tion Agency (Datatilsynet).
Cell lines
The two teratoma cell lines, CRL-7826 and CRL-7732
were purchased from ATCC. The cells were grown to near
confluence before total RNA extraction.
Preparation of RNA
Tissues were ground under liquid nitrogen. Small RNA
(sRNA) species smaller than 200 nt were enriched with
the mirVana miRNA isolation kit (Ambion, Austin, Texas,
USA). RNA from the different samples was pooled into a
BC and a BN library. RNA from CRL-7826 and CRL-7732
was extracted by guanidinum isothiocyanate/phe-
nol:chloroform extraction (Trizol). The sRNAs were then
separated on a denaturing 12,5% polyacrylamide (PAA)
gel. The population of miRNAs with a length of 15 – 30
and 30 – 100 bases (breast cancer samples) or length 15–
40 (normal breast, teratoma) was obtained by passive elu-
tion of the RNAs from the gel. The sRNAs were then pre-
cipitated with ethanol and dissolved in water.
cDNA synthesis
For cDNA synthesis the sRNAs were first poly(A)-tailed
using poly(A) polymerase followed by ligation of a RNA
adapter to the 5'-phosphate of the sRNAs. First-strand
End variation of miRNA vs. non-miRNA loci Figure 8
End variation of miRNA vs. non-miRNA loci. Distribution of A) 5' end variability and B) 3' end variability for miRNA 
(blue) and non-miRNA loci (yellow). Only loci with at least ten reads were used in this analysis. End variabilities of 0 are omit-
ted from the plot.BMC Medical Genomics 2009, 2:35 http://www.biomedcentral.com/1755-8794/2/35
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cDNA synthesis was then performed using an oligo(dT)-
linker primer and M-MLV-RNAse H- reverse transcriptase.
The resulting cDNAs were then PCR-amplified to about
20 ng/μl using Taq polymerase.
The fusion primers used for PCR amplification were
designed for amplicon sequencing according to the
instructions of 454 Life Sciences. The correct size ranges
(cDNA + flanks) were obtained by separate purification
on 6% PAA-gels. For pool formation the purified cDNAs
were mixed in a molar ratio of 3 +1. The concentration of
the cDNA pool was 11 ng/μl dissolved in 25 μl water.
Sequencing using 454 technology
Amplicons from all preparations were sequenced using
the Genome Sequencer 20 (GS20; Roche) according to the
protocol provided by Marguiles et al. [19], resulting in the
following number of reads for each sample: BC: 302556,
BN: 136139, CRL-7826: 69013, CRL-7732: 64894.
The sequence data is freely accesible and can be down-
loaded from http://people.binf.ku.dk/~krogh/
bmc454paper/. Novel miRNAs are being submitted to
miRBase [4].
Hidden Markov model
We built a profile HMM with states corresponding to the
expected flank-sequences around the cDNA insert. The
cDNA insert itself was modeled by a single state with
fixed, uniform emission probabilities. The model was ini-
tialized with a 0.02 probability of mutation or indels in
any position. A random subset of 10000 sequences was
chosen and scored with the initial model. The score was
calculated as  , where Pmodel is calculated
with the forward algorithm [20], and Pbackground is the prob-
ability given a uniform background model. Sequences
with positive score were then used to train the final
model. By inspection of the score distribution and
sequences, a score cut-off above which all sequences had
recognizable flanking sequences was chosen. All
sequences were scored by the model, and for those that
passed the score cut-off, the cDNA inserts were extracted
using labels predicted by the Viterbi algorithm [20].
Inserts shorter than 18 bases were subsequently discarded,
due to the diffculties of mapping such short sequences.
Mapping sequences to the genome
We used the suffix array based program Vmatch [22] to
map the read sequences to the genome requiring a mini-
mum of 90% identity over the full length alignment. For
each read we selected the set of genomic matches having
maximal identity for the given read. Reads mapping more
than five places with this maximal identity were discarded
from further analysis.
Annotation
Reads that had successfully been mapped to the genome a
maximum of 5 places were annotated according to over-
lap with known annotations, in the following prioritized
order:
MiRNA (Human miRBase 10.1 coordinates from miRbase
[4,5,45,46]. Other ncRNA (the sno/miRNA track down-
loaded from the UCSC genome browser, hg18 [47-49],
and the Rfam, rnaDB, joneseddy, and noncode tracks
from ncRNA.org v.2.0 [50]). Exon (Known Genes exon
entries from the UCSC genome browser). Intron (reads
contained within the Known Genes from the UCSC
genome browser, but not in exons as described above).
Repeat (the repeatmasker, microsatellite, and simplere-
peat tables from the UCSC genome browser).
Mapped reads not overlapping any of these features were
annotated as unknown.
Reads were also mapped against human piRNAs con-
tained in XMLpiRNAV2.zip from rnaDB.org [51] using
Vmatch [22] requiring exact matches.
For assessment of conservation, the conservation scores
from the 'Vertebrate Multiz Alignment & PhastCons Con-
servation (28 Species)' track [52-54] of the UCSC genome
browser was used, and the average calculated over all base
positions in the mature sequence.
Expression analysis
The Z-test described in [24] was used to compare relative
expression values for BN and BC. Only reads of length 19
– 24 were included in the analysis. Fold change was calcu-
lated based on the normalized (ppm) counts. All statisti-
cal tests were performed in R [55].
Constructing genomic miRNA loci
To identify miRNAs among the sequenced reads, we
grouped all genomic matches with read lengths between
19 – 24 nt (reads outside this range are ignored) into
genomic loci based on their locations. Starting with the
genomic match having highest measured read abundance,
we assigned this genomic match and all matches con-
tained within +/- 2 nt to the same locus. This procedure
was repeated iteratively for the remaining genomic
matches, always selecting the remaining genomic match
with highest read abundance for the next locus. The
genomic matches in a constructed miRNA locus represent
a set of sequence variants originating from the same puta-
tive mature miRNA sequence
log
Pmodel
P backgroundBMC Medical Genomics 2009, 2:35 http://www.biomedcentral.com/1755-8794/2/35
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Resolving miRNA precursor candidates into SVM features
For each constructed miRNA locus, we examined the sec-
ondary structure by extracting two genomic sequences
around the genomic match with highest abundance in the
locus. The first extracted sequence started 15 bases 5' of
the match and extended 60 bases 3' of the match – the sec-
ond sequence had the extension lengths reversed. Each of
these was treated independently in the following analysis.
Each potential precursor sequence was folded with RNA-
fold [34-36], and the structure processed and evaluated as
described in [42], calculating a number of attributes
describing both sequence and structural features. In addi-
tion to the features described in [42], we also determined
the miRNA arm and the length of the longest bulge found
in the calculated miRNA:miRNA* duplex.
miRNA precursor classification
The known human miRNAs from miRBase 10.0 were used
as positive examples for the SVM, excluding those where
the mature sequence was annotated as shorter than 19 or
longer than 24 bases. Based on the annotated mature
miRNA coordinates, we constructed miRNA precursors by
extension with 15 and 60 bases as described above. (Since
we do not know in advance which arm of the precursor
hairpin a novel miRNA will be on, this folding was done
in both directions). MiRNAs that did not fold into hairpin
structures using these settings were discarded. The miR-
Base [4] family annotation was used to ensure that family
members were kept together during training.
The negative sets were made by random sampling of pre-
cursors from three different sequence sets: A) the full
human genome (hg18, March 06 assembly). B) a ncRNA
set made by concatenating the non-miRNA sequences
from the 'rfamFull' and 'joneseddy' genome tracks from
ncrna.org [50]. C) A random subset of about 9000 mRNA
sequences from the 'human mRNA track', table all mrna,
via the UCSC genome browser. ¿From each set 3000 –
4000 hairpin structures were sampled randomly, while
requiring that the values for all SVM features were within
the range observed for the miRBase miRNAs. A further
600 – 1000 hairpins were sampled from each set requiring
the values to be between the 0.01 and 0.99 quantiles of
the miRNA distributions, and 100 – 500 hairpins were
sampled requiring values within the 0.1 and 0.9 quantiles.
We used the R e1071 library [56] implementation of an
SVM with radial kernel, using ten-fold cross-validation
and evaluation on an independent test set. A locus was
assigned the highest score obtained by any of its reads.
miRNA end precision
For miRBase mature miRNAs, reads mapping to the anno-
tated mature region relaxed by +/- 4 nucleotides in both
ends were analyzed. We only examined miRNAs having
mapped reads with a summed expression count of at least
3. As a dispersion measure of the mature miRNA end pre-
cision we used the weighted mean absolute deviation
(WMAD) with weights defined by the expression counts
of the reads. Let xa denote the annotated mature miRNA
end position (e.g. 5' end), and for each read ri ∈ r1, r2,...,rn
mapping to the region we denote the expression count ci
and the end position xi:
The same measure was used with signed distances (xi - xa)
instead to infer the directionality of the dispersion relative
to the annotation. For comparisons of miRNA-miRNA*
end precision, the WMAD was calculated relative to the
respective sequences with highest read abundance.
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Additional file 1
Figures of expression of novel miRNA loci. Expression is shown for all 
the putative novel miRNAs described in this paper. Each figure shows the 
genomic coordinates (top row), location of the approximate predicted pre-
cursor hairpin (second row: grey box = mature, white box = miRNA*), 
and all reads mapped to the region. Each bar represents one specific read. 
The bars are colour coded according to samples and expression, as labeled 
in each figure. Thick bars represent perfect matches, thin bars imperfect 
matches. Note that the approximate miRNA* (white box) is a computa-
tional construct, not the actual biological miRNA* expected from the 
locus. This file is best viewed on-screen.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1755-
8794-2-35-S1.pdf]
Additional file 2
Figure of signed end variation of miRNAs. The 219 expressed known 
mature miRNAs with a minimum expression count of 3. A) The distribu-
tion of mean (signed) deviations from the most frequent mature miRNA 
5' end (56 miRNAs with a 5' deviation of 0 are omitted for plotting pur-
poses, minus denotes shorter sequences). B) The distribution of mean 
(signed) deviations from the most frequent mature miRNA 3' end, minus 
denoting shorter sequences. Ten miRNAs with a 3' deviation of 0 are 
omitted.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1755-
8794-2-35-S2.pdf]
Additional file 3
Figures of miRNA-like expression from other ncRNA genes. Two exam-
ples of read expression patterns in predicted hairpins in non-miRNA 
ncRNAs. First example is within a C/D box snoRNA U3 gene (five such 
genes are repeated on chromosome 17). A dominant read of approximate 
size 22 is observed. Second example is within a 18S rRNA related pseu-
dogene. Despite a diffuse expression pattern, there is a dominant species 
of read. Legend: Each figure shows the genomic coordinates (top row), 
location of the approximate predicted precursor hairpin (second row: grey 
box = mature, white box = miRNA*), and all reads mapped to the region. 
Each bar represents one specific read. The bars are colour coded according 
to samples and expression, as labeled in each figure. Thick bars represent 
perfect matches, thin bars imperfect matches. Note that the approximate 
miRNA* (white box) is a computational construct, not the actual biolog-
ical miRNA* expected from the locus. This file is best viewed on-screen.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1755-
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